CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 62 filers reported holding CYTOSORBENTS CORP in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $42,595 | -26.0% | 60,591 | 0.0% | 0.00% | – |
| Q1 2024 | $57,561 | -14.4% | 60,591 | 0.0% | 0.00% | – |
| Q4 2023 | $67,256 | -42.2% | 60,591 | -2.2% | 0.00% | – |
| Q3 2023 | $116,430 | -47.6% | 61,931 | 0.0% | 0.00% | – |
| Q2 2023 | $222,332 | +7.3% | 61,931 | +0.7% | 0.00% | – |
| Q1 2023 | $207,231 | +113.9% | 61,493 | -1.6% | 0.00% | – |
| Q4 2022 | $96,860 | +16.7% | 62,490 | +1.9% | 0.00% | – |
| Q3 2022 | $83,000 | -38.1% | 61,339 | +0.6% | 0.00% | – |
| Q2 2022 | $134,000 | -27.2% | 60,977 | +5.7% | 0.00% | – |
| Q1 2022 | $184,000 | -7.5% | 57,684 | +21.3% | 0.00% | – |
| Q4 2021 | $199,000 | – | 47,543 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 1,772,000 | $13,379,000 | 1.58% |
| Sargent Investment Group, LLC | 856,315 | $6,465,000 | 1.53% |
| Avenir Corp | 1,366,549 | $10,317,000 | 0.82% |
| CM Management, LLC | 150,000 | $1,133,000 | 0.82% |
| Winning Points Advisors, LLC | 136,900 | $1,035,000 | 0.78% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,397,000 | 0.46% |
| SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,847,000 | 0.15% |
| Redmile Group, LLC | 1,304,369 | $9,848,000 | 0.15% |
| Granahan Investment Management | 1,003,546 | $7,577,000 | 0.14% |
| ACT CAPITAL MANAGEMENT, LLC | 35,000 | $265,000 | 0.14% |